ROLKE JAMES (Chief Executive Officer) reported 1 transaction at REVELATION BIOSCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/1/2026ACC: 0001193125-26-201769
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-10.12K
Net shares
Net seller
$11.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
10.12K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.12K
Price / share
$1.13
Trade value
$11.43K
% of position
4.5%
4/30/2026
224.85K→214.74K
Total
Net shares
−10.12K
Net value
-$11.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2026 | F · Tax Withholding | −10.12K | $1.13 | $11.43K | 4.5% | 224.85K | 214.74K |
| Total | −10.12K | -$11.43K | ||||||
Derivative Transactions0
No derivative transactions reported